| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2024 | 337 | 3,311,202 | AAPL, WSO, MSFT, FICO | 13F-HR | 2/3/2025 | 000105305525000001 |
| Q3 2024 | 327 | 3,354,355 | WSO, AAPL, MSFT, FICO | 13F-HR | 10/24/2024 | 000105305524000005 |
| Q2 2024 | 326 | 3,143,507 | MSFT, WSO, AAPL, FICO | 13F-HR | 7/29/2024 | 000105305524000003 |
| Q1 2024 | 332 | 3,143,238 | MSFT, WSO, AAPL, CPRT | 13F-HR | 5/10/2024 | 000105305524000002 |
| Q4 2023 | 315 | 2,956,892 | WSO, AAPL, MSFT, FICO | 13F-HR | 2/12/2024 | 000105305524000001 |
| Q3 2023 | 301 | 2,673,884 | WSO, AAPL, MSFT, CPRT | 13F-HR | 11/9/2023 | 000105305523000004 |
| Q2 2023 | 306 | 2,765,231 | AAPL, WSO, MSFT, CPRT | 13F-HR | 8/7/2023 | 000105305523000003 |
| Q1 2023 | 308 | 2,557,784 | AAPL, WSO, MSFT, CPRT | 13F-HR | 5/12/2023 | 000105305523000002 |
| Q4 2022 | 320 | 2,489,136 | MSFT, AAPL, WSO, PFE | 13F-HR | 1/27/2023 | 000105305523000001 |
| Q3 2022 | 303 | 2,302,635 | AAPL, MSFT, WSO, CPRT | 13F-HR | 11/9/2022 | 000105305522000004 |
| Q2 2022 | 285 | 2,320,207 | MSFT, AAPL, WSO, PFE | 13F-HR | 8/8/2022 | 000105305522000003 |
| Q1 2022 | 285 | 2,633,155 | MSFT, AAPL, WSO, CPRT | 13F-HR | 5/12/2022 | 000105305522000002 |
| Q4 2021 | 262 | 2,748,837 | MSFT, AAPL, WSO, CPRT | 13F-HR | 2/11/2022 | 000105305522000001 |
| Q3 2021 | 256 | 2,455,314 | MSFT, AAPL, CPRT, WSO | 13F-HR | 11/12/2021 | 000105305521000004 |
| Q2 2021 | 244 | 2,473,811 | MSFT, AAPL, WSO, CPRT | 13F-HR | 8/3/2021 | 000105305521000003 |
| Q1 2021 | 232 | 2,274,575 | MSFT, AAPL, WSO, CPRT | 13F-HR | 5/7/2021 | 000105305521000002 |
| Q4 2020 | 230 | 2,201,692 | MSFT, AAPL, CPRT, WSO | 13F-HR | 2/10/2021 | 000105305521000001 |
| Q3 2020 | 232 | 2,055,329 | MSFT, AAPL, WSO, CPRT | 13F-HR | 11/12/2020 | 000105305520000004 |
| Q2 2020 | 276 | 1,859,247 | MSFT, AAPL, TYL, WSO | 13F-HR | 8/10/2020 | 000105305520000003 |
| Q1 2020 | 266 | 1,556,214 | MSFT, AAPL, TYL, PFE | 13F-HR | 5/5/2020 | 000105305520000002 |
| Q4 2019 | 235 | 1,824,716 | MSFT, AAPL, CPRT, PFE | 13F-HR | 2/5/2020 | 000105305520000001 |
| Q3 2019 | 254 | 1,758,317 | MSFT, CPRT, PFE, AAPL | 13F-HR | 11/8/2019 | 000105305519000004 |
| Q2 2019 | 258 | 1,730,053 | PFE, MSFT, GSIE, CPRT | 13F-HR | 7/24/2019 | 000105305519000003 |
| Q1 2019 | 263 | 1,644,442 | PFE, MSFT, AAPL, CPRT | 13F-HR | 4/25/2019 | 000105305519000002 |
| Q4 2018 | 256 | 1,443,668 | PFE, MSFT, AAPL, DGRW | 13F-HR | 1/31/2019 | 000105305519000001 |
| Q3 2018 | 298 | 1,693,369 | PFE, MSFT, AAPL, GSIE | 13F-HR | 11/2/2018 | 000105305518000005 |
| Q2 2018 | 265 | 1,479,615 | PFE, MSFT, AAPL, CPRT | 13F-HR | 8/3/2018 | 000105305518000003 |
| Q1 2018 | 269 | 1,463,734 | PFE, MSFT, AAPL, DGRW | 13F-HR | 4/25/2018 | 000105305518000002 |
| Q4 2017 | 269 | 1,494,205 | PFE, MSFT, AAPL, DGRW | 13F-HR | 2/5/2018 | 000105305518000001 |
| Q3 2017 | 263 | 1,406,574 | PFE, AAPL, MSFT, JNJ | 13F-HR | 10/30/2017 | 000105305517000004 |
| Q2 2017 | 274 | 1,392,162 | PFE, AAPL, MSFT, JNJ | 13F-HR | 7/27/2017 | 000105305517000003 |
| Q1 2017 | 282 | 1,342,620 | PFE, AAPL, MSFT, JNJ | 13F-HR | 5/11/2017 | 000105305517000002 |
| Q4 2016 | 278 | 1,267,516 | PFE, MSFT, DGRW, JNJ | 13F-HR | 2/10/2017 | 000105305517000001 |
| Q3 2016 | 264 | 1,226,786 | PFE, JNJ, MSFT, AAPL | 13F-HR | 11/4/2016 | 000105305516000011 |
| Q2 2016 | 254 | 1,227,074 | PFE, JNJ, MSFT, XOM | 13F-HR | 8/11/2016 | 000105305516000010 |
| Q1 2016 | 175 | 665,804 | PFE, JNJ, XOM, MSFT | 13F-HR | 5/3/2016 | 000105305516000007 |
| Q4 2015 | 182 | 697,048 | PFE, JNJ, MSFT, XOM | 13F-HR | 2/2/2016 | 000105305516000006 |
| Q3 2015 | 192 | 705,990 | PFE, JNJ, XOM, AAPL | 13F-HR | 10/30/2015 | 000105305515000005 |
| Q2 2015 | 201 | 777,633 | PFE, AAPL, XOM, ABBV | 13F-HR | 8/6/2015 | 000105305515000004 |
| Q1 2015 | 204 | 799,178 | PFE, XOM, JNJ, AAPL | 13F-HR | 5/15/2015 | 000105305515000003 |
| Q4 2014 | 202 | 795,567 | PFE, XOM, JNJ, ABBV | 13F-HR | 2/18/2015 | 000105305515000001 |
| Q3 2014 | 205 | 762,577 | PFE, XOM, JNJ, ABBV | 13F-HR | 11/5/2014 | 000105305514000005 |
| Q2 2014 | 204 | 757,989 | PFE, XOM, JNJ, ABBV | 13F-HR | 8/20/2014 | 000105305514000004 |
| Q1 2014 | 199 | 747,152 | PFE, XOM, JNJ, ABBV | 13F-HR | 5/8/2014 | 000105305514000003 |
| Q4 2013 | 204 | 729,253 | PFE, XOM, ABBV, JNJ | 13F-HR | 2/25/2014 | 000105305514000002 |